Table 2. Results of clinical survey in the pregnant group (n = 13) and control group (n = 13).
pregnant group | control group | |||||||
---|---|---|---|---|---|---|---|---|
none | mild | extensive | severe | none | mild | extensive | severe | |
Musculosceletal pain | 10/13 (76.9%) | 0/13 (0%) | 3/13 (23.1%) | 0/13 (0%) | 7/13 (53.8%) | 6/13 (46.2%) | 0/13 (0%) | 0/13 (0%) |
subjective tumor growth | 0/13 (0%) | 2/13 (15.4%) | 4/13 (30.8%) | 7/13 (53.8%) | 7/13 (53.8%) | 5/13 (38.5%) | 1/13 (7.7%) | 0/13 (0%) |
new tumors | 0/13 (0%) | 4/13 (30.8%) | 2/13 (15.4%) | 7/13 (53.8%) | 7/13 (53.8%) | 4/13 (30.8%) | 2/13 (15.4%) | 0/13 (0%) |
MPNST | 13/13 (100%) | 0/13 (0%) | 0/13 (0%) | 0/13 (0%) | 13/13 (100%) | 0/13 (0%) | 0/13 (0%) | 0/13 (0%) |
gestational hypertension | 10/13 (76.9%) | 0/13 (0%) | 0/13 (0%) | 3/13 (23.1%) | n.a | n.a | n.a | n.a |
pre term delivery | 13/13 (100%) | 0/13 (0%) | 0/13 (0%) | 0/13 (0%) | n.a | n.a | n.a | n.a |